Cargando…

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Detalles Bibliográficos
Autores principales: Tomczyk, Sara, Bennett, Nancy M., Stoecker, Charles, Gierke, Ryan, Moore, Matthew R., Whitney, Cynthia G., Hadler, Stephen, Pilishvili, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: U.S. Centers for Disease Control 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779453/
https://www.ncbi.nlm.nih.gov/pubmed/25233284
_version_ 1783294543169323008
author Tomczyk, Sara
Bennett, Nancy M.
Stoecker, Charles
Gierke, Ryan
Moore, Matthew R.
Whitney, Cynthia G.
Hadler, Stephen
Pilishvili, Tamara
author_facet Tomczyk, Sara
Bennett, Nancy M.
Stoecker, Charles
Gierke, Ryan
Moore, Matthew R.
Whitney, Cynthia G.
Hadler, Stephen
Pilishvili, Tamara
author_sort Tomczyk, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-5779453
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher U.S. Centers for Disease Control
record_format MEDLINE/PubMed
spelling pubmed-57794532018-03-06 Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Tomczyk, Sara Bennett, Nancy M. Stoecker, Charles Gierke, Ryan Moore, Matthew R. Whitney, Cynthia G. Hadler, Stephen Pilishvili, Tamara MMWR Morb Mortal Wkly Rep Articles U.S. Centers for Disease Control 2014-09-19 /pmc/articles/PMC5779453/ /pubmed/25233284 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Articles
Tomczyk, Sara
Bennett, Nancy M.
Stoecker, Charles
Gierke, Ryan
Moore, Matthew R.
Whitney, Cynthia G.
Hadler, Stephen
Pilishvili, Tamara
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
title Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
title_full Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
title_fullStr Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
title_full_unstemmed Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
title_short Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
title_sort use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the advisory committee on immunization practices (acip)
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779453/
https://www.ncbi.nlm.nih.gov/pubmed/25233284
work_keys_str_mv AT tomczyksara useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT bennettnancym useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT stoeckercharles useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT gierkeryan useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT moorematthewr useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT whitneycynthiag useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT hadlerstephen useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip
AT pilishvilitamara useof13valentpneumococcalconjugatevaccineand23valentpneumococcalpolysaccharidevaccineamongadultsaged65yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesacip